Trial Profile
An Open-Label, Randomized, 4-Way Crossover Study to Assess the Relative Bioavailability of 4 New Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 22 Nov 2012 New trial record
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.